This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Godfrey, M. Articles by Kuroki, Y. Search for Related Content PubMed PubMed Citation Articles by Godfrey, M. Articles by Kuroki, Y.

American Journal of Pathology, Vol 146, 1414-1421, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Abnormal morphology of fibrillin microfibrils in fibroblast cultures from patients with neonatal Marfan syndrome

M Godfrey, M Raghunath, J Cisler, CL Bevins, A DePaepe, M Di Rocco, J Gregoritch, K Imaizumi, P Kaplan and Y Kuroki
University of Nebraska Medical Center, Omaha 68198-5430, USA.

The Marfan syndrome (MFS) is a connective tissue disorder manifested by variable and pleiotropic features in the skeletal, ocular, and cardiovascular systems. The average life span in MFS is about 35 years. A group with much more severe cardiovascular disease and a mean life span of approximately 1 year also exists. We refer to this latter group as "neonatal Marfan syndrome" (nMFS). Fibrillin defects are now known to be the cause of MFS and nMFS. Immunofluorescence studies were the first to demonstrate this association. Here we describe immunofluorescence studies in a series of 10 neonates and summarize their salient clinical features. In vitro accumulation of fibrillin reactive fibers was assayed using monoclonal antibodies to fibrillin in hyperconfluent fibroblast cultures. As was previously observed in MFS, fibroblast cultures from nMFS patients showed an apparent decrease in accumulation of immunostainable fibrillin. Significantly, however, the morphology of the immunostained fibrils in the nMFS cultures were abnormal and differed not only from control cultures, but also from those seen in cultures of MFS fibroblasts. The nMFS fibrils appeared short, fragmented, and frayed, characteristics that are not seen in MFS. Both the clinical and fibrillin morphology data provide evidence to suggest a useful subclassification of nMFS in the spectrum of MFS.

This article has been cited by other articles:

				G. Lin, K. Tiedemann, T. Vollbrandt, H. Peters, B. Batge, J. Brinckmann, and D. P. Reinhardt Homo- and Heterotypic Fibrillin-1 and -2 Interactions Constitute the Basis for the Assembly of Microfibrils J. Biol. Chem., December 20, 2002; 277(52): 50795 - 50804. [Abstract] [Full Text] [PDF]

				P. N Robinson and M. Godfrey The molecular genetics of Marfan syndrome and related microfibrillopathies J. Med. Genet., January 1, 2000; 37(1): 9 - 25. [Abstract] [Full Text]

				D. P. Reinhardt, R. N. Ono, and L. Y. Sakai Calcium Stabilizes Fibrillin-1 against Proteolytic Degradation J. Biol. Chem., January 10, 1997; 272(2): 1231 - 1236. [Abstract] [Full Text] [PDF]